Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. 20/08/2026			5-day change	1st Jan Change
13.37 ^MXN	-0.45%		-3.26%	-25.27%

07-24	Genomma Lab Internacional, S.A.B. de C.V., Q2 2026 Earnings Call, Jul 23, 2026
07-23	Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	13,036	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-25.4%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	17,489	16,595	15,873
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-21.37%	-5.11%	-4.35%
P/E	14.9x	12x	13.1x	11.7x	11.1x	5.22x	6.27x	5.51x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	0.92x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.1x	-0.4x	0.4x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.7x	0.68x	0.64x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	0.93x	0.86x	0.78x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	3.84x	3.73x	3.33x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.17x	4.1x	3.67x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	15.8x	7.97x	6.89x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	6.33%	12.5%	14.5%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8342	1.232	1.585
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	6.24%	9.21%	11.9%
EPS ²	1.44	1.41	1.08	2.14	1.61	2.56	2.132	2.425
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	32.6%	57.8%	65.4%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	18,724	19,192	20,340
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,558	4,448	4,764
EBIT ¹	3,063	3,263	3,224	3,982	3,760	4,198	4,052	4,330
Net income ¹	1,451	1,397	1,031	2,137	1,607	2,194	2,177	2,457
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	4,453	3,559	2,837
Reference price ²	21.48	16.94	14.16	25.13	17.89	13.37	13.37	13.37
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	975,033	-	-
Announcement Date	23/02/22	22/02/23	21/02/24	26/02/25	25/02/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	5.22x	0.93x	3.84x	6.24%	769M
ELI LILLY AND COMPANY	35.55x	12.84x	26.06x	0.55%	1,109B
JOHNSON & JOHNSON	29.74x	-	-	2.01%	644B
ABBVIE INC.	33.42x	7.74x	16.11x	2.62%	463B
ROCHE HOLDING AG	20.72x	4.91x	12.16x	2.69%	371B
NOVARTIS AG	22.47x	5.78x	14.33x	2.76%	301B
ASTRAZENECA PLC	21.12x	4.35x	12.35x	2.02%	256B
AMGEN INC.	27.43x	7.09x	12.59x	2.33%	234B
NOVO NORDISK A/S	13.47x	4.79x	10.05x	3.81%	205B
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	178B
Average	16.53x	6.09x	14.69x	2.73%	376.18B
Weighted average by Cap.	25.33x	8.43x	18.53x	1.92%